When an antidepressant lengthens the QT interval, does that translate into more cardiovascular events?

This episode reviews randomized-trial analyses of antidepressant-related QTc changes and early cardiovascular events; an observational study of buprenorphine initiation during concurrent alcohol and opioid withdrawal; and a target-trial emulation examining renal outcomes with SGLT2 inhibitors and GLP-1 receptor agonists according to albuminuria status.